Preventing problems after cancer

By Raquel Maurier
(from left) U of A medical researchers Lesley Mitchell and Maury Pinsk with Lisa McDermott, whose daughter went through cancer treatment and had blood-clot complications

Medical researchers at the University of Alberta are part of a national team that has one common vision—to prevent long-term complications from childhood cancer treatment.

The researchers will initially test blood samples of those who survived childhood to see which genetic biomarkers made the survivors more susceptible to developing common post-cancer complications, such as , hearing loss, kidney failure or bone marrow transplant rejection. In the fifth and final year of funding of the $4.3-million grant, researchers will start a pilot study in which deemed to be at risk of these complications will be given medications to prevent the noted health problems. Ultimately, the researchers hope to screen all children with cancer before their treatment starts, in hopes of preventing the complications in the first place.

Each team across the country is recruiting patients for each arm of the study. And each site has a principal investigator who is the national lead in charge of one specific aspect of the research. In Edmonton, principal investigator Lesley Mitchell is in charge of the research arm zeroing in on blood clots. She is a researcher and an associate professor in the Department of Pediatrics with the Faculty of Medicine & Dentistry and an adjunct associate professor with the School of Public Health. She notes that children who have had cancer are one of the largest groups of children to suffer from blood clots, a side-effect of the cancer and the treatment.

“Twenty to 30 years ago children didn’t survive cancer,” says Mitchell, who has spent more than 20 years researching the issue of blood clots in children who have this disease. “Thanks to advances in pediatric medicine and research, children are surviving cancer, but they are living with long-term complications of treatment for the disease. We want to help these children and prevent these complications from happening in the first place.”

This video is not supported by your browser at this time.
Lesley Mitchell and Maury Pinsk describe their research

Some children who suffer from blood clots can have symptoms such as swelling or passing out. Others don’t exhibit any symptoms at all, such as one child whose multiple veins to his heart had been completely blocked by blood clots, so the body created numerous additional veins to the heart to keep blood flowing. But the problem, says Mitchell, is that these newly created veins don’t work as well as the original ones. Blood clots can lead to complications later in life such as being at risk for developing multiple clots and rupturing of the newly created veins.

Pediatric oncologist Maria Spavor, an Edmonton co-investigator and assistant clinical professor with the Department of Pediatrics, will be involved in enrolling child and adult patients for all arms of the study through her role as medical director of the Kids With Cancer Society Survivor Program, a multidisciplinary Edmonton clinic that follows survivors of . The clinic provides lifelong screening and support for survivors, assisting them with the long-term medical and psychosocial complications of cancer treatment.

"Late complications of cancer treatment are a reality for so many survivors of childhood cancer,” says Spavor. “Our hope is that we will reduce the significant impact these cause in their lives, ultimately giving every survivor the quality of life they so deserve."

Maury Pinsk, another Edmonton co-investigator, is based in pediatric nephrology and is an associate professor in the Department of Pediatrics. He will lead the kidney-failure part of the study in Edmonton.

“Kidney injury from the medicines used to treat cancer is not well recognized in pediatric cancer unless children end up with complete kidney failure on dialysis,” he says.

The $4.3-million grant was jointly funded by the Canadian Institutes of Health Research (CIHR), the C17 Research Network in Edmonton, the Canadian Cancer Society, the Hospital for Sick Children in Toronto, and the Pediatric Oncology Group of Ontario.

Overall, CIHR and other funding organizations have invested $12 million to support the work of four different research teams across Canada.

add to favorites email to friend print save as pdf

Related Stories

Kids born with HIV growing up well

Apr 21, 2011

( -- Once facing an almost certain death sentence, most children born with HIV are now faring well into adolescence and adulthood, according to a newly published study co-authored by Tulane infectious diseases ...

Most cancer-related blood clots occur in outpatients

Dec 13, 2011

(Medical Xpress) -- In a study of nearly 18,000 cancer patients, University of Rochester Medical Center researchers found that when blood clots develop – a well-known and serious complication of cancer treatment – ...

Recommended for you

Pepper and halt: Spicy chemical may inhibit gut tumors

5 hours ago

Researchers at the University of California, San Diego School of Medicine report that dietary capsaicin – the active ingredient in chili peppers – produces chronic activation of a receptor on cells lining ...

Expressive writing may help breast cancer survivors

6 hours ago

Writing down fears, emotions and the benefits of a cancer diagnosis may improve health outcomes for Asian-American breast cancer survivors, according to a study conducted by a researcher at the University of Houston (UH).

Taking the guesswork out of cancer therapy

12 hours ago

Researchers and doctors at the Institute of Bioengineering and Nanotechnology (IBN), Singapore General Hospital (SGH) and National Cancer Centre Singapore (NCCS) have co-developed the first molecular test ...

Brain tumour cells found circulating in blood

13 hours ago

(Medical Xpress)—German scientists have discovered rogue brain tumour cells in patient blood samples, challenging the idea that this type of cancer doesn't generally spread beyond the brain.

International charge on new radiation treatment for cancer

14 hours ago

(Medical Xpress)—Imagine a targeted radiation therapy for cancer that could pinpoint and blast away tumors more effectively than traditional methods, with fewer side effects and less damage to surrounding tissues and organs.

User comments